These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12616652)

  • 1. [Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
    Isobe T; Matsumura A; Anno I; Nagatomo Y; Yoshizawa T; Itai Y; Nose T
    No Shinkei Geka; 2003 Feb; 31(2):167-72. PubMed ID: 12616652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
    Isobe T; Akutsu H; Yamamoto T; Shiigai M; Masumoto T; Nakai K; Takano S; Anno I; Matsumura A
    No Shinkei Geka; 2011 May; 39(5):485-90. PubMed ID: 21512199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
    Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
    Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma.
    Valonen PK; Griffin JL; Lehtimäki KK; Liimatainen T; Nicholson JK; Gröhn OH; Kauppinen RA
    NMR Biomed; 2005 Jun; 18(4):252-9. PubMed ID: 15884096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
    Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
    Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
    J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopic evaluation of brain tissue metabolism after irradiation for pediatric brain tumors in long-term survivors: a report of two cases.
    Blamek S; Wydmański J; Sokół M; Matulewicz L; Boguszewicz L
    Acta Neurochir Suppl; 2010; 106():191-4. PubMed ID: 19812947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
    Ng WH; Lim T
    J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
    Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
    Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H-MRSI of radiation effects in normal-appearing white matter: dose-dependence and impact on automated spectral classification.
    Lee MC; Pirzkall A; McKnight TR; Nelson SJ
    J Magn Reson Imaging; 2004 Apr; 19(4):379-88. PubMed ID: 15065160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
    Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.